Everhart Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,180
Closed -$225K 341
2025
Q1
$225K Buy
+3,180
New +$225K 0.03% 310